S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This healthcare stock making a buzz with 160% growth
This infrastructure construction stock: Is it ready to pop?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
Is Roku worth a second look after the earnings panic selloff?
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Is The Trade Desk signaling the rebound of digital advertising?
bluebird bio stock is ripe for a 400% institutional short squeeze

Sonnet BioTherapeutics (SONN) News Today

$1.86
+0.09 (+5.08%)
(As of 02/26/2024 ET)
SourceHeadline
MarketBeat logoOvid Therapeutics (NASDAQ:OVID) vs. Sonnet BioTherapeutics (NASDAQ:SONN) Critical Review
americanbankingnews.com - February 25 at 3:24 AM
finance.yahoo.com logoSonnet BioTherapeutics Holdings First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - February 17 at 9:28 AM
MarketBeat logoChardan Capital Lowers Sonnet BioTherapeutics (NASDAQ:SONN) Price Target to $30.00
americanbankingnews.com - February 17 at 3:20 AM
finance.yahoo.com logoSonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
finance.yahoo.com - February 14 at 10:41 AM
msn.com logoNasdaq panel expected to decide on Yield10 listing within next month
msn.com - February 7 at 9:08 PM
markets.businessinsider.com logoBTIG Keeps Their Buy Rating on Sonnet BioTherapeutics Holdings (SONN)
markets.businessinsider.com - January 1 at 8:32 AM
msn.com logoSonnet BioTherapeutics files for $100M mixed shelf
msn.com - December 22 at 8:14 PM
finance.yahoo.com logoSonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
finance.yahoo.com - December 21 at 11:12 AM
markets.businessinsider.com logoBuy Rating Affirmed for Sonnet BioTherapeutics Amid Promising Oncology Trials and Financial Fortitude
markets.businessinsider.com - December 16 at 10:11 AM
finance.yahoo.com logoSonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
finance.yahoo.com - December 14 at 7:38 PM
finance.yahoo.com logoSonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
finance.yahoo.com - October 31 at 8:51 AM
benzinga.com logoWhat's Happening With Sonnet BioTherapeutics (SONN) Shares?
benzinga.com - October 26 at 3:19 PM
markets.businessinsider.com logoDow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
markets.businessinsider.com - October 25 at 4:02 PM
msn.com logoSonnet BioTherapeutics down 32%, prices $4.55M stock offering
msn.com - October 25 at 4:02 PM
benzinga.com logoWhy Sonnet BioTherapeutics (SONN) Stock Is Getting Hammered
benzinga.com - October 25 at 4:02 PM
marketwatch.com logoSonnet BioTherapeutics Shares Slide Premarket After Stock Offering
marketwatch.com - October 25 at 9:30 AM
msn.com logoWhy Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?
msn.com - October 25 at 9:30 AM
finance.yahoo.com logoSonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
finance.yahoo.com - October 25 at 9:30 AM
finance.yahoo.com logoSonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
finance.yahoo.com - October 17 at 1:15 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Ambrx Biopharma (AMAM) and Aldeyra Therapeutics (ALDX)
markets.businessinsider.com - October 17 at 8:14 AM
finance.yahoo.com logoSonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology
finance.yahoo.com - September 20 at 10:10 AM
msn.com logoSonnet BioTherapeutics regains listing compliance
msn.com - September 19 at 1:35 PM
finance.yahoo.com logoSonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance
finance.yahoo.com - September 19 at 1:35 PM
marketbeat.com logo
marketbeat.com - September 1 at 10:07 AM
marketbeat.com logo
marketbeat.com - September 1 at 9:40 AM
msn.com logoSonnet BioTherapeutics launches 1-for-22 reverse stock split
msn.com - August 31 at 8:10 PM
benzinga.com logoWhy Sonnet BioTherapeutics Stock (SONN) Is Getting Obliterated
benzinga.com - August 31 at 8:10 PM
finance.yahoo.com logoSonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
finance.yahoo.com - August 31 at 8:10 PM
markets.businessinsider.com logoChardan Capital Keeps Their Buy Rating on Sonnet BioTherapeutics Holdings (SONN)
markets.businessinsider.com - August 17 at 7:05 AM
marketwatch.com logoSonnet BioTherapeutics Shares Rise After FDA Approves Drug Trial
marketwatch.com - August 16 at 4:04 PM
finance.yahoo.com logoSonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US
finance.yahoo.com - August 16 at 9:50 AM
finanznachrichten.de logoSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
finanznachrichten.de - August 14 at 9:19 AM
finance.yahoo.com logoSonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
finance.yahoo.com - August 14 at 9:19 AM
investorplace.com logoWhy Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
investorplace.com - July 31 at 12:06 PM
finanznachrichten.de logoSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
finanznachrichten.de - July 31 at 9:32 AM
finance.yahoo.com logoSonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
finance.yahoo.com - July 31 at 9:32 AM
finance.yahoo.com logoBeat the Market the Zacks Way: Vertiv, Costco, Sonnet BioTherapeutics in Focus
finance.yahoo.com - July 3 at 8:29 AM
seekingalpha.com logoSonnet BioTherapeutics stock plummets 20% on $2.25M registered direct offering
seekingalpha.com - June 29 at 8:57 AM
msn.com logoWhy Sonnet BioTherapeutics (SONN) Stock Is Nosediving
msn.com - June 28 at 2:07 PM
finanznachrichten.de logoSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
finanznachrichten.de - June 28 at 8:51 AM
finance.yahoo.com logoSonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
finance.yahoo.com - June 28 at 8:51 AM
markets.businessinsider.com logoSonnet BioTherapeutics Holdings (SONN) Receives a Buy from EF Hutton
markets.businessinsider.com - June 26 at 1:55 PM
finance.yahoo.com logoSonnet BioTherapeutics Announces Presentations at the 2023 Cytokine-Based Drug Development Summit and Provides Preliminary Update on the SON-080 Study in Chemotherapy-Induced Peripheral Neuropathy
finance.yahoo.com - June 23 at 1:03 PM
finance.yahoo.com logoSonnet BioTherapeutics Announces Regulatory Approval for Initiation of a Clinical Trial of SON-1010 Combined with Atezolizumab
finance.yahoo.com - June 20 at 10:07 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: SAB Biotherapeutics (SABS) and Geron (GERN)
markets.businessinsider.com - June 15 at 9:15 AM
finance.yahoo.com logoSONN - Sonnet BioTherapeutics Holdings, Inc.
finance.yahoo.com - June 9 at 7:21 PM
benzinga.com logoSonnet BioTherapeutics Holdings shares are trading higher after EF Hutton initiated a Buy rating on the stock and announced a $6.70 price target.
benzinga.com - May 25 at 4:38 PM
markets.businessinsider.com logoExpert Ratings for Sonnet BioTherapeutics
markets.businessinsider.com - May 25 at 10:27 AM
finance.yahoo.com logoPankaj Mohan Bought 149% More Shares In Sonnet BioTherapeutics Holdings
finance.yahoo.com - May 19 at 6:58 AM
marketwatch.com logo8-K: Sonnet BioTherapeutics Holdings, Inc.
marketwatch.com - May 12 at 2:56 AM
Get Sonnet BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter.



SONN Media Mentions By Week

SONN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SONN
News Sentiment

-0.71

0.45

Average
Medical
News Sentiment

SONN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SONN Articles
This Week

1

1

SONN Articles
Average Week

Get Sonnet BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SONN) was last updated on 2/27/2024 by MarketBeat.com Staff